$0.62 EPS Expected for Cantel Medical Corp. (CMD) This Quarter

Analysts expect Cantel Medical Corp. (NYSE:CMD) to post earnings of $0.62 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cantel Medical’s earnings. Cantel Medical posted earnings per share of $0.59 during the same quarter last year, which indicates a positive year over year growth rate of 5.1%. The firm is scheduled to announce its next quarterly earnings report on Thursday, March 14th.

According to Zacks, analysts expect that Cantel Medical will report full-year earnings of $2.60 per share for the current fiscal year. For the next fiscal year, analysts forecast that the business will post earnings of $2.92 per share, with EPS estimates ranging from $2.90 to $2.93. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that cover Cantel Medical.

Cantel Medical (NYSE:CMD) last issued its earnings results on Thursday, November 29th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.02. Cantel Medical had a return on equity of 16.73% and a net margin of 9.87%. The firm had revenue of $225.59 million for the quarter, compared to analysts’ expectations of $227.70 million.

Several brokerages have weighed in on CMD. Sidoti reduced their price objective on Cantel Medical from $142.00 to $120.00 and set a “buy” rating on the stock in a research note on Friday, September 28th. Raymond James reduced their price objective on Cantel Medical from $115.00 to $108.00 and set an “outperform” rating on the stock in a research note on Friday, September 28th. Finally, ValuEngine cut Cantel Medical from a “buy” rating to a “hold” rating in a research note on Friday, September 28th.

Shares of CMD stock traded up $1.28 during trading hours on Monday, hitting $79.13. The stock had a trading volume of 208,028 shares, compared to its average volume of 223,370. Cantel Medical has a one year low of $69.36 and a one year high of $130.92. The company has a current ratio of 2.21, a quick ratio of 1.44 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $3.25 billion, a price-to-earnings ratio of 31.53 and a beta of 1.21.

The business also recently disclosed a Semi-Annual dividend, which will be paid on Thursday, January 31st. Shareholders of record on Thursday, January 17th will be paid a dividend of $0.10 per share. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.09. The ex-dividend date of this dividend is Wednesday, January 16th. Cantel Medical’s payout ratio is presently 7.97%.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

Recommended Story: What is the Federal Reserve?

Get a free copy of the Zacks research report on Cantel Medical (CMD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply